New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Listen to Story Police seized 54,000 bottles of cough syrup worth over Rs 8 crore Abu Taher from Assam arrested for smuggling cough syrup bottles Police intercepted truck with contraband hidden under ...

Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...

The diabetes drug semaglutide ... The results of this study have been published in Nature Medicine and presented simultaneously at the annual congress of the American Society of Nephrology.

Whooping cough, a serious and sometimes fatal disease, is on the rise across the U.S., often affecting young children and babies and sometimes resembling a cold in its early symptoms. The Centers ...

But, when you look more closely, at an individual level, more complex patterns exist that can be harnessed to improve disease prediction," added Dr Ewan Pearson, Professor of Diabetes Medicine ...

A 48-week oral semaglutide treatment regimen for type 2 diabetes (T2D) reduces weight and improves liver steatosis, liver stiffness, and liver enzyme levels in patients with metabolic dysfunction ...

Delhi pollution and Health Concerns: Anyone experiencing high-grade fever, cough, or cold symptoms should ... Intervention Pulmonology & Sleep Medicine, Yatharth Hospital, Noida Extension told ...

People with type 2 diabetes who eat low-carb may be able to discontinue medication Study finds low-carbohydrate diet may improve beta-cell function in people with type 2 diabetes Date: October 22 ...

Minneapolis-based Target on Tuesday said it would reduce the cost of Target-owned and national brands, including food and beverages, everyday basics like cough medicine, toys and other holiday gifts.

Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate disappointed in phase 2, disclosed (PDF) the setback as part of a wider ...